This study is looking at the long-term safety of a medicine called pirtobrutinib for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Participants should have already taken part in another study before joining this one. Treatment will be given every 4 weeks and the study is expected to last about 5 years.
The trial's ID number is NCT07218341. This is a Phase 4 trial, which means it is looking at how well the treatment works and how safe it is. The trial is FDA-regulated and aims to include about 150 participants.
Who can join
Adults aged 18 and older can join the study. It is open to both men and women who are currently in the earlier related study. The trial team will confirm who is eligible to participate.
Conditions
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Everyone in the study will receive either pirtobrutinib or idelalisib, both taken by mouth. Participants will be placed in groups based on the medicine they receive, but this will not be done by chance. There are no blindfolded assignments in the study.
Where
This trial is enrolling at 9 locations. Recruiting sites are listed first.
Cancer Specialists, LLC
Jacksonville, Florida
Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York
Recruiting
Arizona Oncology Associates, P.C. - HOPE
Tucson, Arizona
Not Yet Recruiting
Cayuga Cancer Center
Ithaca, New York
Not Yet Recruiting
Minnesota Oncology Hematology, P.A.
Coon Rapids, Minnesota
Not Yet Recruiting
Mitchell Cancer Institute
Mobile, Alabama
Not Yet Recruiting
Oncology Hematology Care Inc
Cincinnati, Ohio
Not Yet Recruiting
Texas Oncology - Paris
Fort Worth, Texas
Not Yet Recruiting
Study contact
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Elected to the National Academy of Medicine. Treats leukemia and myelodysplastic syndrome. The main doctor for adults with blood cancers, like leukemia, lymphoma, and myeloma. Recognized at state, national or international level.
Professor and transplant specialist, UC Davis. Treats leukemia, lymphoma and multiple myeloma. The main doctor for adults with blood cancers, like leukemia, lymphoma, and myeloma. Recognized at state, national or international level.